US4330001060 - Common Stock
HIMS & HERS HEALTH INC
NYSE:HIMS (11/7/2024, 5:12:41 PM)
After market: 23.65 +0.03 (+0.13%)23.62
+0.2 (+0.85%)
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,046 full-time employees. The company went IPO on 2019-09-09. The Company’s digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The firm connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.
HIMS & HERS HEALTH INC
2269 Chestnut St, #523
San Francisco CALIFORNIA 94123
P: 14158510195
CEO: Andrew Dudum
Employees: 1046
Website: https://www.forhims.com/
Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?
The company expects to enjoy many GLP-1 tailwinds in 2025.
Hims stock jumped late Monday after the online pharmacy beat expectations.
Here you can normally see the latest stock twits on HIMS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: